Literature DB >> 24990152

Lack of CCM1 induces hypersprouting and impairs response to flow.

Tara M Mleynek1, Aubrey C Chan1, Michael Redd2, Christopher C Gibson3, Chadwick T Davis4, Dallas S Shi4, Tiehua Chen5, Kandis L Carter5, Jing Ling6, Raquel Blanco7, Holger Gerhardt8, Kevin Whitehead9, Dean Y Li10.   

Abstract

Cerebral cavernous malformation (CCM) is a disease of vascular malformations known to be caused by mutations in one of three genes: CCM1, CCM2 or CCM3. Despite several studies, the mechanism of CCM lesion onset remains unclear. Using a Ccm1 knockout mouse model, we studied the morphogenesis of early lesion formation in the retina in order to provide insight into potential mechanisms. We demonstrate that lesions develop in a stereotypic location and pattern, preceded by endothelial hypersprouting as confirmed in a zebrafish model of disease. The vascular defects seen with loss of Ccm1 suggest a defect in endothelial flow response. Taken together, these results suggest new mechanisms of early CCM disease pathogenesis and provide a framework for further study. Published by Oxford University Press 2014. This work is written by (a) US Government employee (s) and is in the public domain in the US.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24990152      PMCID: PMC4222362          DOI: 10.1093/hmg/ddu342

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  30 in total

Review 1.  The mouse retina as an angiogenesis model.

Authors:  Andreas Stahl; Kip M Connor; Przemyslaw Sapieha; Jing Chen; Roberta J Dennison; Nathan M Krah; Molly R Seaward; Keirnan L Willett; Christopher M Aderman; Karen I Guerin; Jing Hua; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06       Impact factor: 4.799

Review 2.  Molecular basis of the effects of shear stress on vascular endothelial cells.

Authors:  Yi-Shuan J Li; Jason H Haga; Shu Chien
Journal:  J Biomech       Date:  2005-10       Impact factor: 2.712

Review 3.  Endothelial cell migration during angiogenesis.

Authors:  Laurent Lamalice; Fabrice Le Boeuf; Jacques Huot
Journal:  Circ Res       Date:  2007-03-30       Impact factor: 17.367

Review 4.  Vascular development in the zebrafish.

Authors:  Aniket V Gore; Kathryn Monzo; Young R Cha; Weijun Pan; Brant M Weinstein
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

5.  santa and valentine pattern concentric growth of cardiac myocardium in the zebrafish.

Authors:  John D Mably; Lesley P Chuang; Fabrizio C Serluca; Manzoor-Ali P K Mohideen; Jau-Nian Chen; Mark C Fishman
Journal:  Development       Date:  2006-08       Impact factor: 6.868

Review 6.  [131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies].

Authors:  P Otten; G P Pizzolato; B Rilliet; J Berney
Journal:  Neurochirurgie       Date:  1989       Impact factor: 1.553

7.  CCM1 regulates vascular-lumen organization by inducing endothelial polarity.

Authors:  Maria Grazia Lampugnani; Fabrizio Orsenigo; Noemi Rudini; Luigi Maddaluno; Gwénola Boulday; Francoise Chapon; Elisabetta Dejana
Journal:  J Cell Sci       Date:  2010-04-01       Impact factor: 5.285

Review 8.  Genetics of cavernous angiomas.

Authors:  Pierre Labauge; Christian Denier; Francoise Bergametti; Elisabeth Tournier-Lasserve
Journal:  Lancet Neurol       Date:  2007-03       Impact factor: 44.182

9.  MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices.

Authors:  W Brian Saunders; Kayla J Bayless; George E Davis
Journal:  J Cell Sci       Date:  2005-05-03       Impact factor: 5.285

10.  The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases.

Authors:  Kevin J Whitehead; Aubrey C Chan; Sutip Navankasattusas; Wonshill Koh; Nyall R London; Jing Ling; Anne H Mayo; Stavros G Drakos; Christopher A Jones; Weiquan Zhu; Douglas A Marchuk; George E Davis; Dean Y Li
Journal:  Nat Med       Date:  2009-01-18       Impact factor: 53.440

View more
  17 in total

Review 1.  Vascular heterogeneity and specialization in development and disease.

Authors:  Michael Potente; Taija Mäkinen
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-24       Impact factor: 94.444

2.  Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation.

Authors:  Christopher C Gibson; Weiquan Zhu; Chadwick T Davis; Jay A Bowman-Kirigin; Aubrey C Chan; Jing Ling; Ashley E Walker; Luca Goitre; Simona Delle Monache; Saverio Francesco Retta; Yan-Ting E Shiu; Allie H Grossmann; Kirk R Thomas; Anthony J Donato; Lisa A Lesniewski; Kevin J Whitehead; Dean Y Li
Journal:  Circulation       Date:  2014-12-08       Impact factor: 29.690

3.  The cerebral cavernous malformation pathway controls cardiac development via regulation of endocardial MEKK3 signaling and KLF expression.

Authors:  Zinan Zhou; David R Rawnsley; Lauren M Goddard; Wei Pan; Xing-Jun Cao; Zoltan Jakus; Hui Zheng; Jisheng Yang; J Simon C Arthur; Kevin J Whitehead; Dean Li; Bin Zhou; Benjamin A Garcia; Xiangjian Zheng; Mark L Kahn
Journal:  Dev Cell       Date:  2015-01-26       Impact factor: 12.270

4.  NIR-II window tracking of hyperglycemia induced intracerebral hemorrhage in cerebral cavernous malformation deficient mice.

Authors:  Abdul K Parchur; Zhi Fang; Jaidip M Jagtap; Gayatri Sharma; Christopher Hansen; Shayan Shafiee; Wenquan Hu; Qing R Miao; Amit Joshi
Journal:  Biomater Sci       Date:  2020-08-21       Impact factor: 7.590

5.  CCM proteins control endothelial β1 integrin dependent response to shear stress.

Authors:  Zuzana Macek Jilkova; Justyna Lisowska; Sandra Manet; Claude Verdier; Valerie Deplano; Christian Geindreau; Eva Faurobert; Corinne Albigès-Rizo; Alain Duperray
Journal:  Biol Open       Date:  2014-11-28       Impact factor: 2.422

6.  Novel Murine Models of Cerebral Cavernous Malformations.

Authors:  Matthew R Detter; Robert Shenkar; Christian R Benavides; Catherine A Neilson; Thomas Moore; Rhonda Lightle; Nicholas Hobson; Le Shen; Ying Cao; Romuald Girard; Dongdong Zhang; Erin Griffin; Carol J Gallione; Issam A Awad; Douglas A Marchuk
Journal:  Angiogenesis       Date:  2020-07-24       Impact factor: 9.596

Review 7.  Cerebral Cavernous Malformation: From Mechanism to Therapy.

Authors:  Daniel A Snellings; Courtney C Hong; Aileen A Ren; Miguel A Lopez-Ramirez; Romuald Girard; Abhinav Srinath; Douglas A Marchuk; Mark H Ginsberg; Issam A Awad; Mark L Kahn
Journal:  Circ Res       Date:  2021-06-24       Impact factor: 23.213

8.  KLF4 is a key determinant in the development and progression of cerebral cavernous malformations.

Authors:  Roberto Cuttano; Noemi Rudini; Luca Bravi; Monica Corada; Costanza Giampietro; Eleanna Papa; Marco Francesco Morini; Luigi Maddaluno; Nicolas Baeyens; Ralf H Adams; Mukesh K Jain; Gary K Owens; Martin Schwartz; Maria Grazia Lampugnani; Elisabetta Dejana
Journal:  EMBO Mol Med       Date:  2016-01-01       Impact factor: 12.137

9.  Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.

Authors:  Zinan Zhou; Alan T Tang; Weng-Yew Wong; Sharika Bamezai; Lauren M Goddard; Robert Shenkar; Su Zhou; Jisheng Yang; Alexander C Wright; Matthew Foley; J Simon C Arthur; Kevin J Whitehead; Issam A Awad; Dean Y Li; Xiangjian Zheng; Mark L Kahn
Journal:  Nature       Date:  2016-03-30       Impact factor: 49.962

10.  Micro-CT Imaging Reveals Mekk3 Heterozygosity Prevents Cerebral Cavernous Malformations in Ccm2-Deficient Mice.

Authors:  Jaesung P Choi; Matthew Foley; Zinan Zhou; Weng-Yew Wong; Naveena Gokoolparsadh; J Simon C Arthur; Dean Y Li; Xiangjian Zheng
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.